Next-Generation IVD Market - Global Forecast 2026-2032

The next-generation in vitro diagnostics (IVD) market is experiencing dynamic transformation, reshaping how diagnostics are integrated into healthcare delivery and impacting operational models across the sector. Senior leadership teams are required to adopt agile decision-making and sophisticated risk management strategies to successfully navigate this environment.

Market Snapshot: Next-Generation IVD Market Size and Growth

The next-generation in vitro diagnostics (IVD) market advanced from USD 69.24 billion in 2025 to USD 73.09 billion in 2026 and is projected to maintain a CAGR of 6.86%, ultimately reaching USD 110.20 billion by 2032. This notable expansion highlights significant commercial potential for diagnostics developers, supply chain operators, and procurement leaders across the healthcare system.

Scope & Segmentation Coverage

This report delivers comprehensive segmentation and regional coverage, offering vital intelligence for market entry, competitive positioning, and resource allocation. Senior stakeholders can leverage this segmentation to inform tailored strategies for growth, compliance, and investment prioritization.

Product Types: Instruments, reagents and kits, and software and services each have specific distribution and customer support needs, requiring aligned commercial models.
Technology Types: Clinical chemistry, immunoassay—including CLIA, ELISA, and FIA—plus microbiology (both culture-based and molecular), and molecular diagnostics such as isothermal, PCR, and sequencing are central segments influencing adoption dynamics.
End Users: Diagnostic laboratories, hospitals and clinics, point-of-care facilities, and research institutes each feature unique procurement cycles and service expectations, leading to diversified decision criteria and buying patterns.
Applications: Autoimmune, cardiology, infectious disease, neurology, and oncology are key clinical areas, each demanding customized integration, clinical workflow support, and adoption facilitation.
Test Modalities: Qualitative, quantitative, and semi-quantitative modalities are offered, adaptable across blood, saliva, tissue, and urine sample types, influencing test reliability and utility in different care settings.
Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific each present specific challenges and opportunities related to regulation, manufacturing, distribution infrastructure, and market access.

Key Takeaways: Strategic Insights for Senior Leaders

Converging diagnostic innovations, including molecular, immunoassay, and digital analytics, are driving improved clinical accuracy and faster turnaround for patient results.
Movement toward decentralized testing models is requiring agile supply chains, more responsive distribution channels, and expanded integration support for point-of-care setups.
Regulatory trends emphasize data integrity, cybersecurity, and seamless product interoperability, requiring ongoing collaboration between engineering and compliance teams.
Clear demonstration of clinical effectiveness and economic benefit now underpins procurement and reimbursement choices, directing focus on robust evidence generation programs.
Significant variation in demand and supply complexity across regions elevates the importance of market-specific adaptation, regulatory navigation, and supply resilience to secure competitive positioning.
Service differentiation, including predictive maintenance and digital connectivity, is fostering stronger and longer customer relationships within diverse clinical environments.

Tariff Impact: Trade Policy Implications on Sourcing and Operations

Ongoing changes in trade and tariff regulations have prompted diagnostic manufacturers and healthcare purchasers to reassess sourcing and operational strategies. Tariff modifications are encouraging organizations to diversify supply chains, evaluate alternative manufacturing locations, and build new sourcing partnerships. In response, many healthcare providers are adapting procurement models and, in some cases, accelerating moves to source products locally. These adaptations can influence total cost of ownership, alter service models, and necessitate scenario-based contingency planning to ensure operational agility for future shifts in trade policy.

Methodology & Data Sources

Research combines structured interviews with laboratory directors, clinical specialists, and procurement leaders, alongside secondary analysis of peer-reviewed publications, regulatory filings, and technical standards. The approach integrates competitive intelligence from product documentation and industry filings, while scenario analysis and segment overlays provide a robust basis for actionable insight.

Why This Report Matters

Enables executive teams to align product portfolios and operational strategies with rapidly changing market dynamics in the IVD landscape.
Supports commercial leaders with actionable segmentation data, enhancing effectiveness in go-to-market planning, pricing, and partnership formation across diverse regional and customer needs.
Offers validated, multi-sourced analysis for informed M&A decisions, supply chain improvements, and innovation strategies, ultimately helping mitigate risk exposure in complex markets.

Conclusion

Organizations that synchronize technology investment, evidence-driven value creation, and operational adaptability will be best positioned for continued success in the evolving next-generation IVD market.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Next-Generation IVD Market, by Product Type

8.1. Instruments
8.1.1. Chemistry Analyzers
8.1.2. Immunoassay Analyzers
8.1.3. PCR Instruments
8.2. Reagents & Kits
8.2.1. Clinical Chemistry Reagents
8.2.2. Immunoassay Reagents
8.2.3. Molecular Diagnostics Reagents
8.3. Software & Services
8.3.1. Data Management Software
8.3.2. Maintenance Services

9. Next-Generation IVD Market, by Technology

9.1. Clinical Chemistry
9.1.1. Electrochemical
9.1.2. Photometric
9.2. Immunoassay
9.2.1. Clia
9.2.2. Elisa
9.2.3. Fia
9.3. Microbiology
9.3.1. Culture Based
9.3.2. Molecular
9.4. Molecular Diagnostic
9.4.1. Isothermal Amplification
9.4.2. PCR Based
9.4.3. Sequencing Based

10. Next-Generation IVD Market, by Test Type

10.1. Qualitative
10.2. Quantitative
10.3. Semi Quantitative

11. Next-Generation IVD Market, by Sample Type

11.1. Blood
11.2. Saliva
11.3. Tissue
11.4. Urine

12. Next-Generation IVD Market, by Application

12.1. Autoimmune Diseases
12.1.1. Celiac
12.1.2. Lupus
12.1.3. Rheumatoid Arthritis
12.2. Cardiology
12.2.1. Cardiac Markers
12.2.2. Lipids
12.3. Infectious Diseases
12.3.1. COVID-19
12.3.2. Hepatitis
12.3.3. Hiv
12.3.4. Tuberculosis
12.4. Neurology
12.4.1. Alzheimer’s Disease
12.4.2. Parkinson’s Disease
12.5. Oncology
12.5.1. Hematological
12.5.2. Solid Tumor

13. Next-Generation IVD Market, by End User

13.1. Diagnostic Laboratories
13.1.1. Hospital Laboratories
13.1.2. Reference Laboratories
13.2. Hospitals & Clinics
13.2.1. Secondary Care Hospitals
13.2.2. Tertiary Care Centers
13.3. Point Of Care
13.4. Research Institutes

14. Next-Generation IVD Market, by Region

14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific

15. Next-Generation IVD Market, by Group

15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO

16. Next-Generation IVD Market, by Country

16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea

17. United States Next-Generation IVD Market
18. China Next-Generation IVD Market

19. Competitive Landscape

19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. ABL SA Group
19.6. Agilent Technologies Inc.
19.7. Archer by Integrated DNA Technologies, Inc.
19.8. Becton, Dickinson and Company
19.9. Biomérieux SA
19.10. BioVendor - Laboratorní medicína A.S.
19.11. Cerba Research NV
19.12. Curetis N.V.
19.13. Danaher Corporation
19.14. F. Hoffmann-La Roche Ltd.
19.15. Fapon Biotech Inc.
19.16. Fulgent Genetics, Inc.
19.17. Geneseeq Technology Inc.
19.18. Genomic Labs Ltd.
19.19. Illumina, Inc.
19.20. Invivoscribe, Inc.
19.21. NGenBio Co., Ltd.
19.22. Otsuka Pharmaceutical Co., Ltd.
19.23. Pillar Biosciences Inc.
19.24. QIAGEN GmbH
19.25. Sophia Genetics SA
19.26. Sysmex Europe SE
19.27. Tempus Labs, Inc.
19.28. Thermo Fisher Scientific Inc.
19.29. Trivitron Healthcare
19.30. Vela Diagnostics Holding Pte Ltd.

List of Figures

FIGURE 1. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA NEXT-GENERATION IVD MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CHEMISTRY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CHEMISTRY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CHEMISTRY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELECTROCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELECTROCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PHOTOMETRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PHOTOMETRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PHOTOMETRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY FIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY FIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY FIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CULTURE BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CULTURE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEQUENCING BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEQUENCING BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEQUENCING BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUALITATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUALITATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUALITATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUANTITATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUANTITATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUANTITATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEMI QUANTITATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEMI QUANTITATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEMI QUANTITATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TISSUE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TISSUE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CELIAC, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CELIAC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CELIAC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LUPUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LUPUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LUPUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LIPIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LIPIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LIPIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COVID-19, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COVID-19, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COVID-19, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEPATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HIV, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HIV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HIV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TUBERCULOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TUBERCULOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ALZHEIMER’S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ALZHEIMER’S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ALZHEIMER’S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PARKINSON’S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PARKINSON’S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEMATOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEMATOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEMATOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOLID TUMOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOLID TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TERTIARY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TERTIARY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 217. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 236. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 238. NORTH AMERICA NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 244. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 255. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 256. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 257. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 259. LATIN AMERICA NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 281. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 282. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 283. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 284. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 285. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 286. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 287. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 288. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 289. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 290. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 291. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 292. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 293. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 294. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
TABLE 295. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 296. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 297. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 298. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 299. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 301. EUROPE NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 302. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 303. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 304. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 305. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
TABLE 306. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
TABLE 307. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 308. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
TABLE 309. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 310. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2032 (USD MILLION)
TABLE 311. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2032 (USD MILLION)
TABLE 312. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 313. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 314. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 315. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2032 (USD MILLION)
TABLE 316. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
TABLE 317. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 318. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 319. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 320. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 321. MIDDLE EAST NEXT-GENERATION IVD MARKET SIZE, BY DIAGNO

Companies Mentioned

The key companies profiled in this Next-Generation IVD market report include:

ABL SA Group
Agilent Technologies Inc.
Archer by Integrated DNA Technologies, Inc.
Becton, Dickinson and Company
Biomérieux SA
BioVendor – Laboratorní medicína A.S.
Cerba Research NV
Curetis N.V.
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Fapon Biotech Inc.
Fulgent Genetics, Inc.
Geneseeq Technology Inc.
Genomic Labs Ltd.
Illumina, Inc.
Invivoscribe, Inc.
NGenBio Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Pillar Biosciences Inc.
QIAGEN GmbH
Sophia Genetics SA
Sysmex Europe SE
Tempus Labs, Inc.
Thermo Fisher Scientific Inc.
Trivitron Healthcare
Vela Diagnostics Holding Pte Ltd.

Table Information

Report Attribute	Details
No. of Pages	182
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 73.09 Billion
Forecasted Market Value ( USD ) by 2032	$ 110.2 Billion
Compound Annual Growth Rate	6.8%
Regions Covered	Global
No. of Companies Mentioned	27

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot: Next-Generation IVD Market Size and Growth

Scope & Segmentation Coverage

Key Takeaways: Strategic Insights for Senior Leaders

Tariff Impact: Trade Policy Implications on Sourcing and Operations

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Cancer in Vitro Diagnostics (IVD) Market Report 2025

In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032

Clinical IVD Reagents Market - Global Forecast 2025-2030

In Vitro Diagnostics - A Global Market Overview

In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030